Construction and evaluation of live attenuated myxoma virus vaccines with targeted virulence gene deletions

Mathew M. Adams, Barbara H. van Leeuwen, Peter J. Kerr*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    9 Citations (Scopus)

    Abstract

    Three deletion mutant viruses were constructed as potential vaccines against myxomatosis using the naturally attenuated Uriarra strain of myxoma virus. The viruses had the M007 (encodes a secreted γ-interferon receptor homologue), M010 (encodes an epidermal growth factor homologue) and M011 (encodes an inhibitor of apoptosis in T lymphocytes) genes insertionally inactivated as either ΔM007, ΔM010/M011 or ΔM007/M010/M011. All three viruses induced high serum antibody titres. Rabbits immunized with these deletion mutants were protected from lethal challenge. However, immunization of adult rabbits with ΔM007 or ΔM010/M011 was associated with mild clinical signs that would make these viruses unacceptable as vaccines. The triple gene knock-out virus (ΔM007/M010/M011) termed Ur-TKO was very well tolerated by adult and juvenile rabbits. The low pathogenicity of Ur-TKO was confirmed by pathogenesis studies in domestic and wild rabbits. Crown

    Original languageEnglish
    Pages (from-to)5843-5854
    Number of pages12
    JournalVaccine
    Volume26
    Issue number46
    DOIs
    Publication statusPublished - 29 Oct 2008

    Fingerprint

    Dive into the research topics of 'Construction and evaluation of live attenuated myxoma virus vaccines with targeted virulence gene deletions'. Together they form a unique fingerprint.

    Cite this